Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Veterinary Biomarkers Market Size, Value And Growth Trajectory Through 2030
The veterinary biomarkers market has shown considerable growth in recent years. This market is set to increase from $0.91 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 12.4%. In the past, this growth was influenced by a dependence on conventional diagnostics, restricted biomarker availability, the rising occurrence of animal diseases, traditional veterinary research methodologies, and the limited adoption of preclinical research tools.
The veterinary biomarkers market is projected to experience substantial expansion over the coming years. Its size is forecasted to reach $1.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is largely due to advancements in biomarker discovery, increased investments in veterinary diagnostics, heightened awareness regarding animal health monitoring, the expansion of both companion and production animal sectors, and the adoption of automated biomarker readers and digital platforms. Key trends for this period encompass the broadening of diagnostic biomarker development, an increase in predictive and prognostic biomarker applications, wider adoption of ELISA, PCR, and rapid test kits, greater utilization of advanced biomarker readers and analytical devices, and an intensifying focus on the health of companion and production animals.
Get A Free Sample Report With In-Depth Market Insights:
Veterinary Biomarkers Market Growth Backed By Core Demand Fundamentals
The expanding trend of pet ownership is anticipated to propel the future growth of the veterinary biomarkers market. Pet ownership involves individuals having one or more animals as companions, taking responsibility for their care, providing shelter, and ensuring their overall needs and well-being are met. The rise in pet ownership can be attributed to several factors, including the human desire for companionship, the therapeutic benefits of pets, and an increasing recognition of the positive impact pets have on mental and physical health. Within the context of pet ownership, veterinary biomarkers are crucial for monitoring animal health, facilitating early disease detection, and enabling personalized treatment plans. For instance, in June 2025, according to the Petfood Industry, a US-based organization, 94 million U.S. households owned at least one pet, a notable increase from 82 million in 2023, reflecting a significant surge in pet ownership and rising demand for pet care products and services. Consequently, the increasing pet ownership is driving the growth of the veterinary biomarkers market.
Veterinary Biomarkers Market Segment Landscape: Which Areas Lead Development?
The veterinary biomarkers market covered in this report is segmented –
1) By Product Type: Biomarkers, Kits And Reagents, Biomarker Readers
2) By Disease Type: Inflammatory And Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Other Disease Types
3) By Animal Type: Companion Animals, Production Animals
4) By Application: Disease Diagnostics, Preclinical Research, Other Applications
Subsegments:
1) By Biomarkers: Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers
2) By Kits And Reagents: ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents For Biomarker Detection
3) By Biomarker Readers: Optical Readers, Fluorescence Readers, Luminometers, Real-Time PCR Machines, Microplate Readers
Veterinary Biomarkers Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the veterinary biomarkers market are concentrating on forming strategic alliances to achieve a competitive advantage. These strategic partnerships within the veterinary biomarkers sector involve collaborations between businesses, research institutions, and veterinary practices, aimed at advancing the development and application of diagnostic tools. For example, in November 2025, Bionote USA, a US-based veterinary diagnostics company, launched the Vcheck C1 In-Clinic Chemistry Analyzer. This is an affordable, compact biochemistry testing device designed to broaden point-of-care biomarker and diagnostic capabilities for veterinary practices. The Vcheck C1 allows for the simultaneous analysis of up to 24 biochemical parameters from small animal samples within 10–12 minutes, delivering laboratory-grade accuracy with a straightforward workflow. It supports testing for 34 species, including canine, feline, equine, and bovine patients, complete with validated reference ranges for each. Featuring extensive test panels such as comprehensive chemistry, electrolyte, liver, kidney, and diabetes profiles, the analyzer enables clinicians to quickly diagnose and monitor health conditions without submitting samples to external laboratories. The product’s accessible pricing and support for multiple species are intended to improve access to rapid, in-clinic biomarker diagnostics across a broad spectrum of veterinary settings.
Veterinary Biomarkers Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio‑Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, Ayoxxa Biosystems
View The Full Veterinary Biomarkers Market Report:
Veterinary Biomarkers Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the veterinary biomarkers market in 2025. The regions covered in the veterinary biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
